Roberto Pili

  • 11262 Citations
  • 52 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberto Pili is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications

Dual inhibition of angiopoietin-Tie2 and MET alters the tumor microenvironment and prolongs survival in a metastatic model of renal cell carcinoma

Elbanna, M., Orillion, A. R., Damayanti, N. P., Adelaiye-Ogala, R., Shen, L., Miles, K. M., Chintala, S., Ciamporcero, E., Ramakrishnan, S., Ku, S. Y., Rex, K., Caenepeel, S., Coxon, A. & Pili, R., Jan 1 2020, In : Molecular cancer therapeutics. 19, 1, p. 147-156 10 p.

Research output: Contribution to journalArticle

  • 3 Scopus citations

    Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy

    Affronti, H. C., Rowsam, A. M., Pellerite, A. J., Rosario, S. R., Long, M. D., Jacobi, J. J., Bianchi-Smiraglia, A., Boerlin, C. S., Gillard, B. M., Karasik, E., Foster, B. A., Moser, M., Wilton, J. H., Attwood, K., Nikiforov, M. A., Azabdaftari, G., Pili, R., Phillips, J. G., Casero, R. A. & Smiraglia, D. J., Dec 1 2020, In : Nature communications. 11, 1, 52.

    Research output: Contribution to journalArticle

    Open Access
  • Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma

    Wood, A., George, S., Adra, N., Chintala, S., Damayanti, N. & Pili, R., Aug 1 2020, In : Investigational New Drugs. 38, 4, p. 1108-1116 9 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Antitumor activity and mechanistic characterization of APE1/ReF-1 inhibitors in bladder cancer

    Fishel, M. L., Xia, H., McGeown, J., McIlwain, D. W., Elbanna, M., Craft, A. A., Kaimakliotis, H. Z., Sandusky, G. E., Zhang, C., Pili, R., Kelley, M. R. & Jerde, T. J., 2019, In : Molecular cancer therapeutics. 18, 11, p. 1947-1960 14 p.

    Research output: Contribution to journalArticle

  • A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors

    Michaelson, M. D., Gupta, S., Agarwal, N., Szmulewitz, R., Powles, T., Pili, R., Bruce, J. Y., Vaishampayan, U., Larkin, J., Rosbrook, B., Wang, E., Murphy, D., Wang, P., Lechuga, M. J., Valota, O. & Shepard, D. R., Sep 1 2019, In : Oncologist. 24, 9, p. 1151-e817

    Research output: Contribution to journalArticle

    Open Access